Bart Ghesquiere Selected Research

Bart Ghesquiere Research Topics

4	Neoplasms (Cancer) 04/2024 - 01/2018
3	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 04/2024
1	Triple Negative Breast Neoplasms 12/2023
1	Cardiomegaly (Heart Hypertrophy) 11/2022
1	Fibrosis (Cirrhosis) 11/2022
1	Neuroblastoma 07/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	COVID-19 01/2021
1	Infections 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Lung Injury 01/2019
1	Acute Lung Injury 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Ischemia 01/2018
1	Inflammation (Inflammations) 09/2017

3	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2021
2	EnzymesIBA 04/2024 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2018
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 04/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2024
1	Androgen Receptors (Androgen Receptor)IBA 04/2024
1	LipidsIBA 04/2024
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	ertugliflozinIBA 11/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022
1	SodiumIBA 11/2022
1	SymportersIBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	Sirolimus (Rapamycin)FDA Link 11/2022
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 07/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	GlycogenIBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Interferon Type IIBA 01/2021
1	CarbonIBA 01/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	CytokinesIBA 01/2019
1	Interleukin-13IBA 01/2019
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Prolyl-Hydroxylase InhibitorsIBA 09/2017

3	Therapeutics 04/2024 - 01/2022
1	Drug Therapy (Chemotherapy) 12/2023